AI's Impact on the Drug Targeting Process - with Ramesh Durvasula of Lilly

AI's Impact on the Drug Targeting Process - with Ramesh Durvasula of Lilly

0 Calificaciones
0
Episodio
753 of 1070
Duración
19min
Idioma
Inglés
Formato
Categoría
Economía y negocios

Today's guest is Ramesh Durvasula, Senior Vice President of R&D IT at Lilly. Ramesh joins us on the program today to discuss AI's impact on the drug targeting process, particularly in helping pharmaceutical leaders like Lilly better predict what potential drugs to invest in for bringing to market and when. With increased certainty in drug targeting, Ramesh explains how AI capabilities are driving clinical trials to be used as an alternative form of healthcare. Visit emerj.com/beg1 to learn more about the practical steps for AI deployment for non-technical professionals.


Escucha y lee

Descubre un mundo infinito de historias

  • Lee y escucha todo lo que quieras
  • Más de 1 millón de títulos
  • Títulos exclusivos + Storytel Originals
  • Precio regular: CLP 7,990 al mes
  • Cancela cuando quieras
Suscríbete ahora
Copy of Device Banner Block 894x1036 3
Cover for AI's Impact on the Drug Targeting Process - with Ramesh Durvasula of Lilly

Otros podcasts que te pueden gustar...